中文

睿智医药 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-29
ItemAmountY/Y
Revenue¥0.27B+2.1%
Gross profit¥0.06B
Operating income¥-0.02B
Net income¥-0.02B-372.2%
Gross margin22.1%Net margin -6.8%
Revenue Q/Q-16.1%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.21B77.9%
R&D¥0.02B5.8%
SG&A¥0.06B21.5%
Tax & other¥-0.01B-2.0%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

世纪瑞尔昌红科技*ST动力科泰电源瑞凌股份安居宝新锦动力振东制药新研股份秀强股份华中数控雷曼光电

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies